CAPLIPOINT.BO
CAPLIPOINT.BO
INE475E01026
CAPLIN POINT LABORATORIES LTD.
Loading chart...

Company Profile

Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic formulations and branded products in India. The company provides tablets, capsules, injections, ophthalmic, liquid orals, softgel, capsules, ointments, creams and gels, powder for injections, suppositories, ovules, pre-mix bag, inhalers, and sprays and IV infusion. It also provides dry and syrups, lyophilized vials, prefilled syringes, emulsion injection, ophthalmic droppers, sachets, liquid injectables, topicals, pre-filled syringes, and pre-mix bags. Caplin Point Laboratories Limited was incorporated in 1990 and is headquartered in Chennai, India.

Related stocks

SHILPAMED.BO
SHILPAMED.BO • India
SHILPA MEDICARE LTD.
1,020.35 INR
2.06B USD 1Y +187.4%
JUBLPHARMA.BO
JUBLPHARMA.BO • India
JUBILANT PHARMOVA LIMITED
931.2 INR
1.52B USD 1Y -14.2%
APLLTD.NS
APLLTD.NS • India
ALEMBIC PHARMA LTD
800.95 INR
1.63B USD 1Y -14%
COHANCE.NS
COHANCE.NS • India
COHANCE LIFESCIENCES LTD
441 INR
1.74B USD 1Y -48.6%
PPLPHARMA.NS
PPLPHARMA.NS • India
PIRAMAL PHARMA LIMITED
196.88 INR
2.7B USD 1Y -0.4%
ASTRAZEN.BO
ASTRAZEN.BO • India
ASTRAZENECA PHARMA INDIA LTD.
5,831.85 INR
1.51B USD 1Y -38.5%
NEULANDLAB.BO
NEULANDLAB.BO • India
NEULAND LABORATORIES LTD.
20,879.85 INR
2.77B USD 1Y +35.8%
GRANULES.NS
GRANULES.NS • India
GRANULES INDIA LIMITED
815.25 INR
2.3B USD 1Y +48.5%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
37.7% p.a.
Max Drawdown (5Y)
-42.0%
Sharpe Ratio (5Y)
0.57
Beta Factor
0.42
Size Class
Mega Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (37.7% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -74.4% in the extended horizon.
ende